Expression of proinflammatory cytokines in osteoarthritis of the temporomandibular joint

Archives of Oral Biology

Volumn 53, Issue 10, 2008, Pages 910-915

  Vernal, Rolando ^a,b   Velásquez, Edgar ^c   Gamonal, Jorge ^b   Garcia Sanz, Jose A ^a   Silva, Augusto ^a   Sanz, Mariano ^c  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Cytokines; IL10; IL12; IL17; Inflammation; OA; Osteoarthritis; Temporomandibular disorders; Temporomandibular joint; TMJ

Indexed keywords

AUTACOID; CYTOKINE; MESSENGER RNA;

ADULT; ARTICLE; BIOSYNTHESIS; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; MALE; METABOLISM; METHODOLOGY; OSTEOARTHRITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDER;

ADULT; CYTOKINES; FEMALE; GENE EXPRESSION; HUMANS; INFLAMMATION MEDIATORS; MALE; OSTEOARTHRITIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 49149129234     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2008.04.004     Document Type: Article

References (38)

1. Bjornland T., Gjaerum A.A., and Moystad A. Osteoarthritis of the temporomandibular joint: an evaluation of the effects and complications of corticosteroid injection compared with injection with sodium hyaluronate. J Oral Rehabil 34 (2007) 583-589
2. Johansson A., Unell L., Carlsson G.E., Soderfeldt B., and Halling A. Gender difference in symptoms related to temporomandibular disorders in a population of 50-year-old subjects. J Orofac Pain 17 (2003) 29-35
3. Johansson A., Unell L., Carlsson G.E., Soderfeldt B., and Halling A. Risk factors associated with symptoms of temporomandibular disorders in a population of 50- and 60-year-old subjects. J Oral Rehabil 33 (2006) 473-481
4. de Bont L.G., Boering G., Liem R.S., Eulderink F., and Westesson P.L. Osteoarthritis and internal derangement of the temporomandibular joint: a light microscopic study. J Oral Maxil Surg 44 (1986) 634-643
5. Yamada K., Saito I., Hanada K., and Hayashi T. Observation of three cases of temporomandibular joint osteoarthritis and mandibular morphology during adolescence using helical CT. J Oral Rehabil 31 (2004) 298-305
6. Kaneyama K., Segami N., Sun W., Sato J., and Fujimura K. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99 (2005) 276-284
7. Sandler N.A., Buckley M.J., Cillo J.E., and Braun T.W. Correlation of inflammatory cytokines with arthroscopic findings in patients with temporomandibular joint internal derangements. J Oral Maxil Surg 56 (1998) 534-543
8. Shafer D.M., Assael L., White L.B., and Rossomando E.F. Tumor necrosis factor-alpha as a biochemical marker of pain and outcome in temporomandibular joints with internal derangements. J Oral Maxil Surg 52 (1994) 786-791
9. Wakita T., Mogi M., Kurita K., Kuzushima M., and Togari A. Increase in RANKL:OPG ratio in synovia of patients with temporomandibular joint disorder. J Dent Res 85 (2006) 627-632
10. Tanaka A., Kumagai S., Kawashiri S., Takatsuka S., Nakagawa K., Yamamoto E., et al. Expression of matrix metalloproteinase-2 and -9 in synovial fluid of the temporomandibular joint accompanied by anterior disc displacement. J Oral Pathol Med 30 (2001) 59-64
11. Yoshida K., Takatsuka S., Tanaka A., Hatada E., Nakamura H., Nakagawa K., et al. Aggrecanase analysis of synovial fluid of temporomandibular joint disorders. Oral Dis 11 (2005) 299-302
12. Berglundh T., Liljenberg B., and Lindhe J. Some cytokine profiles of T-helper cells in lesions of advanced periodontitis. J Clin Periodontol 29 (2002) 705-709
13. Fokkema S.J., Loos B.G., Slegte C., and van der Velden U. A type 2 response in lipopolysaccharide (LPS)-stimulated whole blood cell cultures from periodontitis patients. Clin Exp Immunol 127 (2002) 374-378
14. Manoury-Schwartz B., Chiocchia G., Bessis N., Abehsira-Amar O., Batteux F., Muller S., et al. High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J Immunol 158 (1997) 5501-5506
15. Sato K., Suematsu A., Okamoto K., Yamaguchi A., Morishita Y., Kadono Y., et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203 (2006) 2673-2682
16. Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7 (2007) 292-304
17. Nakae S., Nambu A., Sudo K., and Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171 (2003) 6173-6177
18. Sato K., and Takayanagi H. Osteoclasts, rheumatoid arthritis, and osteoimmunology. Curr Opin Rheumatol 18 (2006) 419-426
19. Kotake S., Udagawa N., Takahashi N., Matsuzaki K., Itoh K., Ishiyama S., et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103 (1999) 1345-1352
20. Garcia-Sanz J.A., and Podack E.R. Regulation of perforin gene expression in a T cell hybrid with inducible cytolytic activity. Eur J Immunol 23 (1993) 1877-1883
21. del Prete M.J., Vernal R., Dolznig H., Mullner E.W., and Garcia-Sanz J.A. Isolation of polysome-bound mRNA from solid tissues amenable for RT-PCR and profiling experiments. RNA 13 (2007) 414-421
22. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
23. Carda C., Silvestrini G., Gomez de Ferraris M.E., Peydro A., and Bonucci E. Osteoprotegerin (OPG) and RANKL expression and distribution in developing human craniomandibular joint. Tissue Cell 37 (2005) 247-255
24. Giulietti A., Overbergh L., Valckx D., Decallonne B., Bouillon R., and Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25 (2001) 386-401
25. Thellin O., Zorzi W., Lakaye B., De Borman B., Coumans B., Hennen G., et al. Housekeeping genes as internal standards: use and limits. J Biotechnol 75 (1999) 291-295
26. Takahashi T., Kondoh T., Fukuda M., Yamazaki Y., Toyosaki T., and Suzuki R. Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 (1998) 135-141
27. Fu K., Ma X., Zhang Z., Pang X., and Chen W. Interleukin-6 in synovial fluid and HLA-DR expression in synovium from patients with temporomandibular disorders. J Orofac Pain 9 (1995) 131-137
28. Inanir A., Ozoran K., Tutkak H., and Mermerci B. The effects of calcitriol therapy on serum interleukin-1, interleukin-6 and tumour necrosis factor-alpha concentrations in post-menopausal patients with osteoporosis. J Int Med Res 32 (2004) 570-582
29. Kay J., and Calabrese L. The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. Rheumatology 43 (2004) 2-9
30. Naguwa S.M. Tumor necrosis factor inhibitor therapy for rheumatoid arthritis. Ann NY Acad Sci 1051 (2005) 709-715
31. Seymour G.J., and Gemmell E. Cytokines in periodontal disease: where to from here?. Acta Odontol Scand 59 (2001) 167-173
32. Hamada Y., Kondoh T., Holmlund A.B., Yamamoto M., Horie A., Saito T., et al. Inflammatory cytokines correlated with clinical outcome of temporomandibular joint irrigation in patients with chronic closed lock. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 (2006) 596-601
33. Kim W., Min S., Cho M., Youn J., Min J., Lee S., et al. The role of IL-12 in inflammatory activity of patients with rheumatoid arthritis (RA). Clin Exp Immunol 119 (2000) 175-181
34. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., and de Vries J.E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174 (1991) 1209-1220
35. Moore K.W., O'Garra A., de Waal Malefyt R., Vieira P., and Mosmann T.R. Interleukin-10. Annu Rev Immunol 11 (1993) 165-190
36. Fossiez F., Banchereau J., Murray R., Van Kooten C., Garrone P., and Lebecque S. Interleukin-17. Int Rev Immunol 16 (1998) 541-551
37. Gravallese E.M. Bone destruction in arthritis. Ann Rheum Dis 61 (2002) 84-86
38. Vernal R., Dutzan N., Chaparro A., Puente J., Antonieta Valenzuela M., and Gamonal J. Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Clin Periodontol 32 (2005) 383-389